Detection of an inflammatory myofibroblastic tumor in the testis by FDG-PET/CT; a rare presentation of a rare neoplasm
Maurits Wondergem, Friso M. van der Zant, Lorine B. Meijer-Jorna, Siebe D. Bos et autres
0 citationsSeminars in Nuclear Medicine
Maurits Wondergem
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
89Publications signalées
1769Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentMedical Imaging Techniques and ApplicationsRadiopharmaceutical Chemistry and ApplicationsCardiac Imaging and Diagnostics
Publications récentes
Correction to: Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer
Maarten L. Donswijk, Rosemarijn H. Ettema, Maurits Wondergem, Zing Cheung et autres
0 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging
Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer
Maarten L. Donswijk, Rosemarijn H. Ettema, Maurits Wondergem, Zing Cheung et autres
0 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging
[18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial
Sabine E. Breukers, Robert D. Crommelin, Laura A. Smit, Jan Paul de Boer et autres
1 citationEuropean Journal of Nuclear Medicine and Molecular Imaging
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial
Sabine E. Breukers, Joleen J.H. Traets, Stan W. van Dijk, Itske Fraterman et autres
12 citationsNature Medicine
18F-DCFPyL and 18F-PSMA-JK7 for staging of primary prostate cancer: an interpatient comparison in 500 patients
Maurits Wondergem, Friso M. van der Zant, Sergiy V. Lazarenko, Jeroen Doodeman et autres
0 citationsNuclear Medicine Communications
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer
Maarten L. Donswijk, Rosemarijn H. Ettema, Suzanne van der Gaag, Maurits Wondergem et autres
7 citationsEJNMMI Research
Frequency and characteristics of ectopic parathyroid adenomas in a cohort of patients referred for 18F-fluorocholine PET/CT
Friso M. van der Zant, Maurits Wondergem, Wouter A.M. Broos, Sergiy V. Lazarenko et autres
3 citationsNuclear Medicine Communications
Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences
Evelien J E van Altena, B.H.E. Jansen, Marieke L Korbee, Remco J.J. Knol et autres
22 citationsEuropean Urology Oncology
Bone Scintigraphy in 2 Cases of Complex Regional Pain Syndrome
Friso M. van der Zant, Maurits Wondergem, Remco J.J. Knol
0 citationsClinical Nuclear Medicine
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
Marinus J. Hagens, Pim J. van Leeuwen, Maurits Wondergem, Thierry N. Boellaard et autres
21 citationsJournal of Nuclear Medicine
Detection of prostate cancer recurrences with prostate-specific membrane antigen positron emission tomography after curative radiotherapy: A call for reconsideration of the Phoenix criteria
Estelle Altena, B.H.E. Jansen, Marieke L Korbee, W. Luining et autres
0 citationsEuropean Urology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.